BACKGROUND: Multiple Sclerosis (MS) is a chronic inflammatory disease of the CNS typically affecting younger adults and resulting in neuro-axonal degeneration already at early stages of the disease. Less is known about the effects of a later disease onset (LOMS, onset >50years of age). Analysis of retinal layers by optical coherence tomography (OCT) is a non-invasive method to investigate retinal and neuro-axonal degeneration. We applied OCT to detect differences in retinal damage depending on a later disease manifestation. METHODS: 14 LOMS patients, 14 age- and 14 disease duration-matched normal onset (NOMS) patients with a relapsing remitting disease course and 15 healthy controls (HC) were included. OCT measurement of peripapillary retin...
BackgroundTo determine whether retinal axonal loss is detectable in patients with a clinically isola...
Neuromyelitis optica (NMO) and relapsing-remitting multiple sclerosis (RRMS) are difficult to differ...
BackgroundTo determine whether retinal axonal loss is detectable in patients with a clinically isola...
<p>Multiple sclerosis (MS) is the most prevalent disease caused by the inflammatory demyelinating pr...
BACKGROUND AND PURPOSE: Some 3%-10% of patients with multiple sclerosis (MS) experience disease onse...
Objective: To evaluate changes over 3 years in the thickness of inner retinal layers including the p...
Background: To determine whether retinal axonal loss is detectable in patients with a clinically iso...
Objective: To evaluate changes over 3 years in the thickness of inner retinal layers including the p...
INTRODUCTION:Optical coherence tomography (OCT) with retinal segmentation analysis is a valuable too...
ObjectiveTo evaluate changes over 3 years in the thickness of inner retinal layers including the per...
Axonal loss is thought to be the predominant cause of disability in progressive multiple sclerosis (...
BackgroundTo determine whether retinal axonal loss is detectable in patients with a clinically isola...
Background: Optical coherence tomography can be used to assess retinal degeneration in multiple scle...
A benign form of multiple sclerosis (BMS) is not easily diagnosed, but changes of the retinal gangli...
Purpose: To study the retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL) changes on opti...
BackgroundTo determine whether retinal axonal loss is detectable in patients with a clinically isola...
Neuromyelitis optica (NMO) and relapsing-remitting multiple sclerosis (RRMS) are difficult to differ...
BackgroundTo determine whether retinal axonal loss is detectable in patients with a clinically isola...
<p>Multiple sclerosis (MS) is the most prevalent disease caused by the inflammatory demyelinating pr...
BACKGROUND AND PURPOSE: Some 3%-10% of patients with multiple sclerosis (MS) experience disease onse...
Objective: To evaluate changes over 3 years in the thickness of inner retinal layers including the p...
Background: To determine whether retinal axonal loss is detectable in patients with a clinically iso...
Objective: To evaluate changes over 3 years in the thickness of inner retinal layers including the p...
INTRODUCTION:Optical coherence tomography (OCT) with retinal segmentation analysis is a valuable too...
ObjectiveTo evaluate changes over 3 years in the thickness of inner retinal layers including the per...
Axonal loss is thought to be the predominant cause of disability in progressive multiple sclerosis (...
BackgroundTo determine whether retinal axonal loss is detectable in patients with a clinically isola...
Background: Optical coherence tomography can be used to assess retinal degeneration in multiple scle...
A benign form of multiple sclerosis (BMS) is not easily diagnosed, but changes of the retinal gangli...
Purpose: To study the retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL) changes on opti...
BackgroundTo determine whether retinal axonal loss is detectable in patients with a clinically isola...
Neuromyelitis optica (NMO) and relapsing-remitting multiple sclerosis (RRMS) are difficult to differ...
BackgroundTo determine whether retinal axonal loss is detectable in patients with a clinically isola...